Insulin-releasing and metabolic effects of small molecule GLP-1 receptor agonist 6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline

Baggio, 2007, Biology of incretins: GLP-1 and GIP, Gastroenterology, 132, 2131, 10.1053/j.gastro.2007.03.054 Bailey, 1982, Influence of genetic background and age on the expression of the obese hyperglycaemic syndrome in Aston ob/ob mice, Int. J. Obes., 6, 11 Chen, 2007, A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice, Proc. Natl. Acad. Sci. U. S. A., 104, 943, 10.1073/pnas.0610173104 Eiki, 2009, A selective small molecule glucagon-like peptide-1 secretagogue acting via depolarization-coupled Ca(2+) influx, J. Endocrinol., 201, 361, 10.1677/JOE-08-0528 Flatt, 1981, Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice, Diabetologia, 20, 573, 10.1007/BF00252768 Flatt, 2009, Recent advances in antidiabetic drug therapies targeting the enteroinsular axis, Curr. Drug. Metab., 10, 125, 10.2174/138920009787522124 Gault, 2003, DPP IV resistance and insulin releasing activity of a novel di-substituted analogue of glucose-dependent insulinotropic polypeptide, (Ser2-Asp13)GIP, Cell Biol. Int., 27, 41, 10.1016/S1065-6995(02)00255-X Irwin, 2009, Metabolic effects of sustained activation of the GLP-1 receptor alone and in combination with background GIP receptor antagonism in high fat-fed mice, Diabetes Obes. Metab., 11, 603, 10.1111/j.1463-1326.2009.01036.x Kendall, 2005, Effects of exenatide (exendin-4) on glycemic control over 30weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea, Diabetes Care, 28, 1083, 10.2337/diacare.28.5.1083 Knudsen, 2007, Small-molecule agonists for the glucagon-like peptide 1 receptor, Proc. Natl. Acad. Sci. U. S. A., 104, 937, 10.1073/pnas.0605701104 McClenaghan, 1996, Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion, Diabetes, 45, 1132, 10.2337/diab.45.8.1132 Teng, 2007, Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor, Bioorg. Med. Chem. Lett., 17, 5472, 10.1016/j.bmcl.2007.06.086 Thorens, 1992, Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1, Proc. Natl. Acad. Sci. U. S. A., 89, 8641, 10.1073/pnas.89.18.8641 Tibaduiza, 2001, A small molecule ligand of the glucagon-like peptide 1 receptor targets its amino-terminal hormone binding domain, J. Biol. Chem., 276, 37787, 10.1074/jbc.M106692200 Toft-Nielsen, 2001, Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients, J. Clin. Endocrinol. Metab., 86, 3717, 10.1210/jcem.86.8.7750 Tolhurst, 2009, Nutritional regulation of glucagon-like peptide-1 secretion, J. Physiol., 587, 27, 10.1113/jphysiol.2008.164012